Related references
Note: Only part of the references are listed.239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018
Andrew L. Mammen et al.
NEUROMUSCULAR DISORDERS (2020)
Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level
R. Aggarwal et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement
Meirong Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations
Ying Hou et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016
Yves Allenbach et al.
NEUROMUSCULAR DISORDERS (2018)
Immune-Mediated Necrotizing Myopathy
Iago Pinal-Fernandez et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Statin-naive anti-HMGCR antibody-mediated necrotizing myopathy in China
Yuqiong Jiao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Classification and management of adult inflammatory myopathies
Albert Selva-O'Callaghan et al.
LANCET NEUROLOGY (2018)
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies
Kuberaka Mariampillai et al.
JAMA NEUROLOGY (2018)
Integrated classification of inflammatory myopathies
Y. Allenbach et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy
Eleni Tiniakou et al.
RHEUMATOLOGY (2017)
Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients
Takayuki Kishi et al.
ARTHRITIS CARE & RESEARCH (2017)
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories
M. Alvarado-Cardenas et al.
AUTOIMMUNITY REVIEWS (2016)
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study
Lucile Musset et al.
AUTOIMMUNITY REVIEWS (2016)
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody
Yves Allenbach et al.
BRAIN (2016)
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy
Yurika Watanabe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Anti-TIF1-γ antibody and cancer-associated myositis A clinicohistopathologic study
Ayumi Hida et al.
NEUROLOGY (2016)
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
Masato Kadoya et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies An Observational Study in Japan
Yurika Watanabe et al.
MEDICINE (2015)
The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy
Tae Chung et al.
MUSCLE & NERVE (2015)
Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy
Vidya Limaye et al.
MUSCLE & NERVE (2015)
Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience
Martin Klein et al.
RHEUMATOLOGY (2015)
Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy
Charles D. Kassardjian et al.
JAMA NEUROLOGY (2015)
Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies
Yongpeng Ge et al.
PLOS ONE (2015)
Myopathy with anti-HMGCR antibodies Perimysium and myofiber pathology
Ali Alshehri et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies
Shigeaki Suzuki et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies Inconstant Exposure to Statin
Yves Allenbach et al.
MEDICINE (2014)
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
Laurent Drouot et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
Lucile Musset et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Antibody Levels Correlate With Creatine Kinase Levels and Strength in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Associated Autoimmune Myopathy
Jessie L. Werner et al.
ARTHRITIS AND RHEUMATISM (2012)
Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays
P. J. Waters et al.
NEUROLOGY (2012)
Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
A Novel Autoantibody Recognizing 200-kd and 100-kd Proteins Is Associated With an Immune-Mediated Necrotizing Myopathy
Lisa Christopher-Stine et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Josep Dalmau et al.
LANCET NEUROLOGY (2008)
Share Paper
